WHO creates data base on use of child medicines

Jun 18, 2010

(AP) -- The World Health Organization on Friday issued its first-ever guidance on how to use more than 240 essential medicines for children under 13.

The data provide information on use, dosage and side effects of medicines as well as warnings about which children should not take them, the U.N. health agency said. The 528-page document also tells users about common drug interactions.

"To be effective, medicines must be carefully chosen and the dose adjusted to suit the age, weight and needs of children," said WHO's Dr Hans Hogerzeil.

"Without a global guide, many have had to prescribe medicines based on very limited evidence," he said in a statement.

Some countries have developed their own instructions for giving medicines to children, but there are no universal standards.

The WHO document only exists in English. But the agency recommends that governments use it as a model and translate it into their national language, spokeswoman Fadela Chaib said.

Around 8.8 million children under 5 die every year, many from diseases such as and that could be avoided with the correct use of medicines, according to WHO.

Explore further: New system targets germs in donated blood plasma

More information: http://bit.ly/a9ttEd

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Children's medicine has additives

Mar 11, 2007

Britain's Food Commission finds most over-the-counter medication for young children contains additives that are banned from food for infants and toddlers.

Recommended for you

New system targets germs in donated blood plasma

15 hours ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.